News
The University of Kentucky College of Medicine is excited to share the winners of the third annual Mission, Vision, Pillar, and Enabler (MVPE) Awards.
The University of Kentucky has set the date for its sixth annual Substance Use Research Event (SURE) and registration is currently open.
The University of Kentucky Cannabis Center is sponsoring a seminar series featuring national and international experts on cannabis science.
The following individuals were honored at the University of Kentucky College of Medicine Awards Convocation on Wednesday, Oct. 18, 2023. Winners included those in Bowling Green, Lexington, Morehead, and Northern Kentucky.
Biomedical EducationOutstanding Graduate Student Award:
Jamila Tucker, MS
Burnout is a problem in any profession, but it is rampant in health care. This national problem has been evident recently as the COVID-19 pandemic pushed many learners, practitioners, faculty, and staff to the limit.
The University of Kentucky Cannabis Center is sponsoring a series of seminars featuring national and international experts on cannabis science.
The University of Kentucky College of Medicine is excited to announce that faculty, staff, learners, and trainees will have free access to a leading online resource for medical Spanish proficiency.
CanopyLearn, a Spanish language training program for health care professionals, will be available to the UK College of Medicine community starting Aug. 1.
Na’Tasha Evans, PhD, MEd, is a researcher, published author, champion for female empowerment, and our new vice dean for diversity, equity, and inclusion at the University of Kentucky College of Medicine. Learn more about her goals, her past work, and more in the following Q&A.
Q: What inspired you to pursue a career in research?
The University of Kentucky Cannabis Center is sponsoring a series of seminars featuring national and international experts on cannabis science.
The University of Kentucky is home to a new center that will advance research on the medical use of cannabis.
The UK Cannabis Center will conduct research on the health effects of cannabis, including its risks and benefits when used to treat certain medical conditions.
After being revived with Naloxone in the emergency room, patients immediately enter withdrawal. Cold chills, vomiting, diarrhea – “dope sickness” is what many call it. The feeling is hard to describe, but many people who’ve experienced it or witnessed it say it’s like the worst flu times 10.
A multi-site clinical trial led by researchers at the University of Kentucky Center on Drug and Alcohol Research (CDAR) has demonstrated the effectiveness of CAM2038, a potentially transformative buprenorphine therapy for moderate-to-severe opioid use disorders.
Even with the assistance of detoxification and rehabilitation programs, 80 percent of people attempting recovery from opioid addiction will relapse.
The firm grip of opioid addiction on a person’s life necessitates sustainable therapeutic approaches proven effective through scientific trials and evidence.